Terhi
Laakso
Medical Laboratory Technologist, Institute of Biomedicine
Publications
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1 (2025)
Vaccine
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )